Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET

NCT01699828 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Smoking Cessation
Tobacco Use Cessation

Interventions

DRUG: Buspirone
DRUG: Placebo

Sponsor

Centre for Addiction and Mental Health